search
Back to results

Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy

Primary Purpose

Postoperative Delirium

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
lobectomy
Sponsored by
Zhongnan Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Delirium

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 60 years old; There is no limit on the gender, ASA (American Society of Anesthesiologists )Ⅰ-Ⅲ

Exclusion Criteria:

  • Emergency surgery, severe hepatic and renal dysfunction, shock or coma, psychiatric disease or central nervous system disorder or a history of long-term use of psychiatric medications, cognitive dysfunction, severe arrhythmia or bradycardia, ketamine allergy,drug abuse history and used other sedatives for nearly a week

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    es-ketamine

    saline

    Arm Description

    es-ketamine 0.5mg/kg iv

    iv saline with the same volume of es-ketamine

    Outcomes

    Primary Outcome Measures

    Postoperative Delirium
    Confusion Assessment Method (CAM) or CAM-ICU for patients
    Postoperative Cognitive Assessment
    Montreal Cognitive Assessment

    Secondary Outcome Measures

    Full Information

    First Posted
    May 19, 2021
    Last Updated
    July 8, 2021
    Sponsor
    Zhongnan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04969523
    Brief Title
    Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy
    Official Title
    Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy: a Multicentre, Double-blind, Randomised Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    July 31, 2021 (Anticipated)
    Primary Completion Date
    June 30, 2022 (Anticipated)
    Study Completion Date
    December 31, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Zhongnan Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The purpose of this study is the efficiency of es-ketamine on postoperative delirium among old patients with elective lobectomy
    Detailed Description
    This study aimed to investigate the effect of IV es-ketamine vs saline on the incidence of postoperative delirium. It was hypothesized that IV es-ketamine would reduce the incidence of in-hospital delirium during cardiac surgery lobectomy

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Postoperative Delirium

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    500 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    es-ketamine
    Arm Type
    Experimental
    Arm Description
    es-ketamine 0.5mg/kg iv
    Arm Title
    saline
    Arm Type
    Placebo Comparator
    Arm Description
    iv saline with the same volume of es-ketamine
    Intervention Type
    Procedure
    Intervention Name(s)
    lobectomy
    Intervention Description
    Intravenous es-ketamine 0.5mg/kg or saline during lobectomy
    Primary Outcome Measure Information:
    Title
    Postoperative Delirium
    Description
    Confusion Assessment Method (CAM) or CAM-ICU for patients
    Time Frame
    7 days after operation
    Title
    Postoperative Cognitive Assessment
    Description
    Montreal Cognitive Assessment
    Time Frame
    7 days after operation

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 60 years old; There is no limit on the gender, ASA (American Society of Anesthesiologists )Ⅰ-Ⅲ Exclusion Criteria: Emergency surgery, severe hepatic and renal dysfunction, shock or coma, psychiatric disease or central nervous system disorder or a history of long-term use of psychiatric medications, cognitive dysfunction, severe arrhythmia or bradycardia, ketamine allergy,drug abuse history and used other sedatives for nearly a week

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy

    We'll reach out to this number within 24 hrs